L-glutamine gets marketed as a near-universal fix for "leaky gut," and the real research tells a more precise story: a dramatic effect in one specific, well-defined condition, and almost no effect when you pool the evidence broadly.
The specific trial behind glutamine's reputation
A randomized, double-blind, placebo-controlled trial published in the journal Gut enrolled 106 patients with diarrhea-predominant IBS that had developed after a documented enteric infection, and who had confirmed increased intestinal permeability on a lactulose-mannitol test.[1] Patients took 5 grams of glutamine three times daily, 15 grams total, for 8 weeks.
Why the patient selection here matters so much
This trial did not study IBS broadly. It specifically selected people with a documented trigger, an enteric infection, and a measurable biomarker, confirmed hyperpermeability, before enrollment. That precision is exactly why the results were so strong, and exactly why they do not automatically generalize to everyone with digestive symptoms or a self-diagnosed leaky gut without that same specific history and confirmed permeability issue, a caveat that also applies to strain-specific research like probiotic strains for IBS.
What happens when the evidence gets pooled more broadly
The narrow, best-fit trial
The Gut journal trial above enrolled a precisely defined post-infectious IBS-D population with confirmed hyperpermeability, and found a large, statistically strong effect.The pooled, broader evidence
A systematic review and meta-analysis published in Amino Acids pooled 10 randomized controlled trials, 352 participants total, examining glutamine's effect on intestinal permeability broadly.[2] When all studies were combined, glutamine supplementation did not measurably affect intestinal permeability overall.This is not a contradiction of the trial above; it reflects how much the effect appears to depend on the specific population studied, and it means the general marketing claim that glutamine universally heals leaky gut is not supported once you look past the single best-fit trial.
Other conditions where glutamine has real, if narrower, support
Beyond post-infectious IBS, research has found alanyl-glutamine improved intestinal permeability in HIV patients with diarrhea, and separately reduced diarrhea severity related to certain chemotherapy and antiretroviral drugs.[3] A separate 2021 trial in patients with mixed-type IBS, rather than the specific post-infectious diarrhea subtype, found more modest effects, further supporting the idea that glutamine's benefit is concentrated in specific gut conditions rather than acting as a universal repair agent.
What to do with this
If you have diarrhea-predominant IBS that started after a documented infection, the evidence for glutamine is strong and a reasonable topic to raise with your doctor, ideally alongside testing for confirmed intestinal permeability if that is available to you. If your symptoms do not match that specific profile, the pooled evidence gives less reason for confidence, and glutamine should not be treated as an automatic fix for general digestive discomfort or a self-diagnosed leaky gut without a more specific underlying picture.
